247 related articles for article (PubMed ID: 20534795)
1. Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing.
Sharpe SA; McShane H; Dennis MJ; Basaraba RJ; Gleeson F; Hall G; McIntyre A; Gooch K; Clark S; Beveridge NE; Nuth E; White A; Marriott A; Dowall S; Hill AV; Williams A; Marsh PD
Clin Vaccine Immunol; 2010 Aug; 17(8):1170-82. PubMed ID: 20534795
[TBL] [Abstract][Full Text] [Related]
2. Route of delivery to the airway influences the distribution of pulmonary disease but not the outcome of Mycobacterium tuberculosis infection in rhesus macaques.
Sibley L; Dennis M; Sarfas C; White A; Clark S; Gleeson F; McIntyre A; Rayner E; Pearson G; Williams A; Marsh P; Sharpe S
Tuberculosis (Edinb); 2016 Jan; 96():141-9. PubMed ID: 26723465
[TBL] [Abstract][Full Text] [Related]
3. Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.
Darrah PA; Bolton DL; Lackner AA; Kaushal D; Aye PP; Mehra S; Blanchard JL; Didier PJ; Roy CJ; Rao SS; Hokey DA; Scanga CA; Sizemore DR; Sadoff JC; Roederer M; Seder RA
J Immunol; 2014 Aug; 193(4):1799-811. PubMed ID: 25024382
[TBL] [Abstract][Full Text] [Related]
4. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
[TBL] [Abstract][Full Text] [Related]
5. Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis.
Sharpe SA; Eschelbach E; Basaraba RJ; Gleeson F; Hall GA; McIntyre A; Williams A; Kraft SL; Clark S; Gooch K; Hatch G; Orme IM; Marsh PD; Dennis MJ
Tuberculosis (Edinb); 2009 Nov; 89(6):405-16. PubMed ID: 19879805
[TBL] [Abstract][Full Text] [Related]
6. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
[TBL] [Abstract][Full Text] [Related]
7. Ultra low dose aerosol challenge with Mycobacterium tuberculosis leads to divergent outcomes in rhesus and cynomolgus macaques.
Sharpe S; White A; Gleeson F; McIntyre A; Smyth D; Clark S; Sarfas C; Laddy D; Rayner E; Hall G; Williams A; Dennis M
Tuberculosis (Edinb); 2016 Jan; 96():1-12. PubMed ID: 26786648
[TBL] [Abstract][Full Text] [Related]
8. In vivo electroporation of a codon-optimized BER
Tang J; Cai Y; Liang J; Tan Z; Tang X; Zhang C; Cheng L; Zhou J; Wang H; Yam WC; Chen X; Wang H; Chen Z
Tuberculosis (Edinb); 2018 Dec; 113():65-75. PubMed ID: 30514515
[TBL] [Abstract][Full Text] [Related]
9. Systems approaches to correlates of protection and progression to TB disease.
Fletcher HA
Semin Immunol; 2018 Oct; 39():81-87. PubMed ID: 30316693
[TBL] [Abstract][Full Text] [Related]
10. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.
Verreck FA; Vervenne RA; Kondova I; van Kralingen KW; Remarque EJ; Braskamp G; van der Werff NM; Kersbergen A; Ottenhoff TH; Heidt PJ; Gilbert SC; Gicquel B; Hill AV; Martin C; McShane H; Thomas AW
PLoS One; 2009; 4(4):e5264. PubMed ID: 19367339
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates.
Larsen MH; Biermann K; Chen B; Hsu T; Sambandamurthy VK; Lackner AA; Aye PP; Didier P; Huang D; Shao L; Wei H; Letvin NL; Frothingham R; Haynes BF; Chen ZW; Jacobs WR
Vaccine; 2009 Jul; 27(34):4709-17. PubMed ID: 19500524
[TBL] [Abstract][Full Text] [Related]
12. Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate.
Sampson SL; Mansfield KG; Carville A; Magee DM; Quitugua T; Howerth EW; Bloom BR; Hondalus MK
Vaccine; 2011 Jun; 29(29-30):4839-47. PubMed ID: 21549795
[TBL] [Abstract][Full Text] [Related]
13. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
14. Aerosol vaccines for tuberculosis: a fine line between protection and pathology.
Hokey DA; Misra A
Tuberculosis (Edinb); 2011 Jan; 91(1):82-5. PubMed ID: 21067975
[TBL] [Abstract][Full Text] [Related]
15. Peptides-Based Vaccine MP3RT Induced Protective Immunity Against
Gong W; Liang Y; Mi J; Jia Z; Xue Y; Wang J; Wang L; Zhou Y; Sun S; Wu X
Front Immunol; 2021; 12():666290. PubMed ID: 33981313
[TBL] [Abstract][Full Text] [Related]
16. Process of assay selection and optimization for the study of case and control samples from a phase IIb efficacy trial of a candidate tuberculosis vaccine, MVA85A.
Harris SA; Satti I; Matsumiya M; Stockdale L; Chomka A; Tanner R; O'Shea MK; Manjaly Thomas ZR; Tameris M; Mahomed H; Scriba TJ; Hanekom WA; Fletcher HA; McShane H
Clin Vaccine Immunol; 2014 Jul; 21(7):1005-11. PubMed ID: 24828094
[TBL] [Abstract][Full Text] [Related]
17. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
Kita Y; Okada M; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Takamori Y; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Hum Vaccin; 2011; 7 Suppl():108-14. PubMed ID: 21263229
[TBL] [Abstract][Full Text] [Related]
18. The TB-specific CD4(+) T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans.
Mothé BR; Lindestam Arlehamn CS; Dow C; Dillon MBC; Wiseman RW; Bohn P; Karl J; Golden NA; Gilpin T; Foreman TW; Rodgers MA; Mehra S; Scriba TJ; Flynn JL; Kaushal D; O'Connor DH; Sette A
Tuberculosis (Edinb); 2015 Dec; 95(6):722-735. PubMed ID: 26526557
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.
Gupta T; LaGatta M; Helms S; Pavlicek RL; Owino SO; Sakamoto K; Nagy T; Harvey SB; Papania M; Ledden S; Schultz KT; McCombs C; Quinn FD; Karls RK
Tuberculosis (Edinb); 2018 Dec; 113():179-188. PubMed ID: 30514501
[TBL] [Abstract][Full Text] [Related]
20. Non-Human Primate Models of Tuberculosis.
Peña JC; Ho WZ
Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
